Literature DB >> 8624498

Prostate specific antigen-alpha 2-macroglobulin complexes in prostate cancer patient sera.

M J Heeb1, F España, R F Gittes, J H Griffin.   

Abstract

Quantitative immunoblotting of prostate cancer patient sera revealed that most prostate specific antigen was in complexes with alpha 1-antichymotrypsin or alpha 2-macroglobulin with little of it being free antigen. Complexes of prostate specific antigen with these protease inhibitors in patient sera comigrated during electrophoresis with the respective purified complexes. Each complex was selectively removed from patient sera by absorption with specific antibodies. When prostate specific antigen was added to normal plasma, complexes with alpha 2-macroglobulin appeared first and after 1 hr, the distribution was approximately 40% free antigen, approximately 40% complexes with alpha 2-macroglobulin, and approximately 20% complexes with alpha 1-antichymotrypsin. These data show that prostate specific antigen reacts more readily with alpha 2-macroglobulin than with any other protease inhibitor in plasma and that the antigen complexes with alpha 2-macroglobulin in vivo in cancer patients.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8624498

Source DB:  PubMed          Journal:  Biochem Mol Biol Int        ISSN: 1039-9712


  2 in total

1.  Associations of IgG N-linked oligosaccharide chains and proteases in sera of prostate cancer patients with and without alpha2-macroglobulin deficiency.

Authors:  Yuhsaku Kanoh; Shin Egawa; Shiro Baba; Tohru Akahoshi
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

2.  Prognostic potential of a PSA complex in sera of prostate cancer patients with alpha2-macroglobulin deficiency.

Authors:  Yuhsaku Kanoh; Tadashi Ohara; Shin Egawa; Shiro Baba; Tohru Akahoshi
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.